BIOLASE Kicks off Medical Laser Marketing by Exhibiting at MEDICA 2013
World's Leading Dental Laser Company Embraces Multiple Non-Dental Medical Laser Markets
IRVINE, CA -- (Marketwired) -- 11/22/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, and a pioneer in laser surgery in other medical specialties, today announced that it is exhibiting at MEDICA, the International Trade Fair and the Congress for Medical Technology, Electromedicine, Laboratory Equipment, Diagnostics and Drugs, in Düsseldorf, Germany, this week. The show runs from November 20-23, 2013.
MEDICA is the world's largest medical product trade show and occupies 115,000 square meters of floor space, has 4,500 exhibitors from 70 countries, 17 exhibitor halls, and five exhibition areas. Six of the 17 halls are primarily dedicated to electro medical equipment and medical technology. BIOLASE's booth is located in Hall 10, Stand F24 and listed in the program as 10/F24. BIOLASE's video wall showcases videos of clinical procedures across the full spectrum of dentistry, medicine and animal health.
"With our dental distribution now in 70 countries, our primary objective is to meet prospective medical and veterinary distributors for consideration to represent us and also to gain first-hand information on the laser opportunities in ENT, surgery, dermatology, ophthalmology, podiatry, and other medical markets in the various countries represented at the show," said Federico Pignatelli, Chairman and CEO. "We have been told by staff at the show that they expect approximately 130,000 attendees this year."
"We are exhibiting our flagship Waterlase iPlus all-tissue laser with several new medical accessories, such as fractional handpieces and endoscopic fibers, our four current models of EPIC diode soft-tissue lasers, which include dental, surgical, vet, and pain therapy, as well as our handheld iLase soft-tissue diode laser," said William Brown, Vice President, Business Development and International Sales. "Our theme for the show is 'Biolase Goes Medical' and interest during the show so far has been particularly high for our EPIC-V veterinary laser and EPIC-T pain therapy laser."
During the final two days of the show, the BIOLASE booth will feature Yosef Krespi, M.D., a world leader in office-based ENT laser procedures with in-booth lectures on a range of ENT indications utilizing both EPIC and Waterlase technologies.
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's proprietary laser products incorporate approximately 300 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 24,000 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Google+ at www.google.com/+BIOLASEIrvine, Instagram at www.instagram.com/biolaseinc and YouTube at www.youtube.com/biolasevideos.
BIOLASE®, WaterLase®, and EPIC™ are registered trademarks or trademarks of BIOLASE, Inc.
For further information, please contact:
Michael Porter
Porter, LeVay & Rose, Inc.
212-564-4700
Source: BIOLASE, Inc.
Released November 22, 2013
